Abstract:The removal of analog impurities with a very small sample size presents a major challenge in the purification of high‐valued biochemicals such as those derived from fermentation or herbs. Ganoderic acid T (GA‐T), an antitumor drug candidate, is very difficult to purify from the mycelia of medicinal mushroom Ganoderma lucidum due to co‐purifying analog impurities. A novel pretreatment process with three consecutive chemical conversion steps, namely hydrolysis–acetylation–hydrolysis, was developed to convert two key analog impurities (7‐O‐ethyl GA‐O and GA‐Mk) to GA‐T. It increased the GA‐T amount in the 100 g dried mycelia from the initial 0.444 g to 1.621 g after the pretreatment, representing an apparent yield of 365% for the pretreatment. If the yield basis were the initial GA‐T amount plus the GA‐T amount from 100% conversion of 7‐O‐ethyl GA‐O and GA‐Mk in the crude extract, the yield, termed adjusted yield for the pretreatment in this work, would still reach 90.8%. Furthermore, the subsequent RP‐HPLC purification was considerably enhanced due to the conversion of the analog impurities. This game‐changer strategy achieved a daily GA‐T throughput of 2.9 g with 95% purity (mass based). Even at the laboratory scale, it is now possible to produce a sufficient amount of GA‐T for small‐scale pharmacological and clinical evaluations. The approach of converting analog impurities that are otherwise difficult to remove to the product in a bioseparation process may be useful to achieve enhanced recovery of other medicinally useful natural products. Biotechnol. Bioeng. 2012; 109:754–762. © 2011 Wiley Periodicals, Inc.

Novel Ganoderma triterpenoid saponins from the biotransformation-guided purification of a commercial Ganoderma extract

One-Pot Bi-Enzymatic Cascade Synthesis of Novel Ganoderma Triterpenoid Saponins

Glycosylation of Ganoderic Acid G by Bacillus Glycosyltransferases

A New Triterpenoid Glucoside from a Novel Acidic Glycosylation of Ganoderic Acid A via Recombinant Glycosyltransferase of Bacillus subtilis

Biotransformation-guided purification of a novel glycoside derived from the extracts of Chinese herb Baizhi

Enhanced Recovery of Antitumor Ganoderic Acid T from Ganoderma Lucidum Mycelia by Novel Chemical Conversion Strategy.

Extraction of triterpenoid compounds from <i>Ganoderma Lucidum</i> spore powder through a dual-mode sonication process

Anti-human immunodeficiency virus-1 protease activity of new lanostane-type triterpenoids from Ganoderma sinense.

Extraction of triterpenoid compounds from Ganoderma Lucidum spore powder through a dual-mode sonication process

Microbial transformation of 20(S)-protopanaxatriol-type saponins by Absidia coerulea.

Recent Advances in Biotransformation of Saponins

Triterpenoids and meroterpenoids with α-glucosidase inhibitory activities from the fruiting bodies of Ganoderma australe

Biotransformation of Saponins by Endophytes Isolated from Panax Notoginseng

Optimization of Fermentation Conditions and Product Identification of a Saponin-Producing Endophytic Fungus

Preparation and Isolation of Bioactive Sulfated Derivatives from Water-insoluble Glucan in Ganoderma arum

Primary Studies on Saponins from Solid Fermented Roots of Panax Notoginseng

Functional triterpenoids from medicinal fungi Ganoderma applanatum: A continuous search for antiadipogenic agents

Production of saponin in fermentation process of Sanchi ( Panax notoginseng ) and biotransformation of saponin by Bacillus subtilis

Isolation and Bioactivity Evaluation of Terpenoids from the Medicinal FungusGanoderma Sinense

Preparative Isolation of Triterpenoids from Ganoderma Lucidum by Counter-Current Chromatography Combined with Ph-Zone-Refining

Natural products biotransformation and its application